The femtech market is expected to see annual revenues of more than $1bn by 2024, growing at a compound annual growth rate of 12.9% according to recent data from consultancy group Frost & Sullivan. But femtech, when including more traditional women’s health therapeutics companies alongside tech solutions, has the potential to be a $50bn market by 2025.
In a recent Demy Colton virtual salon, industry experts discussed the “rapid growth” of women’s health, a traditionally “underserved” market.